Age
Item
age: 18 to 60 years.
boolean
C0001779 (UMLS CUI [1])
BMI
Item
bmi between 25 and 29,9 kg/m².
boolean
C1305855 (UMLS CUI [1])
Weight variance
Item
weight variance less than 5% in the last 3 months.
boolean
C0005910 (UMLS CUI [1,1])
C1711260 (UMLS CUI [1,2])
Diabetes mellitus type 2
Item
previous diagnosis of diabetes type 2.
boolean
C0011860 (UMLS CUI [1])
Insulin requirement
Item
insulin requirement, alone or along with oral agents
boolean
C0021641 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
Cognition
Item
capacity to understand the procedures of the study.
boolean
C0009240 (UMLS CUI [1])
Informed consent
Item
to agree voluntarily to participate of the study, signing an informed consent.
boolean
C0021430 (UMLS CUI [1])
Anti-gad antibodies
Item
positive anti-gad antibodies
boolean
C1167897 (UMLS CUI [1])
Laboratory results: failure of insulin production
Item
laboratorial signal of probable failure of insulin production, i. e., seric peptide c lesser than 1 ng/ml.
boolean
C2826772 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0231174 (UMLS CUI [1,3])
Hepatic disease
Item
history of hepatic disease like cirrhosis or chronic active hepatitis.
boolean
C0023895 (UMLS CUI [1])
Serum creatinine measurement
Item
kidney dysfunction (creatinine > 1,4 mg/dl in women and > 1,5 mg/dl in men).
boolean
C0201976 (UMLS CUI [1])
Liver enzymes
Item
hepatic dysfunction: alt and/or ast 3x above upper normal limit.
boolean
C1287351 (UMLS CUI [1])
History of neoplasia
Item
recent history of neoplasia (< 5 years).
boolean
C0260455 (UMLS CUI [1])
Corticosteroid therapy
Item
use of oral or injectable corticosteroids for more than consecutive 14 days in the last three months.
boolean
C0149783 (UMLS CUI [1])